194 related articles for article (PubMed ID: 29996844)
1. Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar.
Tun KM; Jeeyapant A; Myint AH; Kyaw ZT; Dhorda M; Mukaka M; Cheah PY; Imwong M; Hlaing T; Kyaw TH; Ashley EA; Dondorp A; White NJ; Day NPJ; Smithuis F
Malar J; 2018 Jul; 17(1):258. PubMed ID: 29996844
[TBL] [Abstract][Full Text] [Related]
2. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
[TBL] [Abstract][Full Text] [Related]
4. Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda.
Angwe MK; Mwebaza N; Nsobya SL; Vudriko P; Dralabu S; Omali D; Tumwebaze MA; Ocan M
PLoS One; 2024; 19(6):e0305064. PubMed ID: 38837973
[TBL] [Abstract][Full Text] [Related]
5. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India.
Krishna S; Mishra S; Tiwari P; Vishwakarma AK; Khandai S; Shrivastava S; Verma AK; Tiwari S; Barman H; Jhariya S; Tiwari P; Tidgam AS; Varun BM; Singh S; Yerane N; Tembhurne CR; Mandavi PL; Tekam SS; Malik M; Behera KP; Jayswar H; Sonwani K; Diggikar MS; Pradhan MM; Khasotiya SS; Kumar A; Dhingra N; Bustos MDG; Christophel EM; Ringwald P; Kumari R; Shukla MM; Singh N; Das A; Bharti PK
Malar J; 2021 May; 20(1):229. PubMed ID: 34020652
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.
Bonnington CA; Phyo AP; Ashley EA; Imwong M; Sriprawat K; Parker DM; Proux S; White NJ; Nosten F
Malar J; 2017 Nov; 16(1):480. PubMed ID: 29178921
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India.
Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N
Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665
[TBL] [Abstract][Full Text] [Related]
10. Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Retain High Efficacy for Treatment of Uncomplicated
Han KT; Lin K; Myint MK; Thi A; Aye KH; Han ZY; Moe M; Bustos MD; Rahman MM; Ringwald P; Simmons R; Markwalter CF; Plowe CV; Nyunt MM
Am J Trop Med Hyg; 2020 Mar; 102(3):598-604. PubMed ID: 31833468
[TBL] [Abstract][Full Text] [Related]
11. Spread of artemisinin resistance in Plasmodium falciparum malaria.
Ashley EA; Dhorda M; Fairhurst RM; Amaratunga C; Lim P; Suon S; Sreng S; Anderson JM; Mao S; Sam B; Sopha C; Chuor CM; Nguon C; Sovannaroth S; Pukrittayakamee S; Jittamala P; Chotivanich K; Chutasmit K; Suchatsoonthorn C; Runcharoen R; Hien TT; Thuy-Nhien NT; Thanh NV; Phu NH; Htut Y; Han KT; Aye KH; Mokuolu OA; Olaosebikan RR; Folaranmi OO; Mayxay M; Khanthavong M; Hongvanthong B; Newton PN; Onyamboko MA; Fanello CI; Tshefu AK; Mishra N; Valecha N; Phyo AP; Nosten F; Yi P; Tripura R; Borrmann S; Bashraheil M; Peshu J; Faiz MA; Ghose A; Hossain MA; Samad R; Rahman MR; Hasan MM; Islam A; Miotto O; Amato R; MacInnis B; Stalker J; Kwiatkowski DP; Bozdech Z; Jeeyapant A; Cheah PY; Sakulthaew T; Chalk J; Intharabut B; Silamut K; Lee SJ; Vihokhern B; Kunasol C; Imwong M; Tarning J; Taylor WJ; Yeung S; Woodrow CJ; Flegg JA; Das D; Smith J; Venkatesan M; Plowe CV; Stepniewska K; Guerin PJ; Dondorp AM; Day NP; White NJ;
N Engl J Med; 2014 Jul; 371(5):411-23. PubMed ID: 25075834
[TBL] [Abstract][Full Text] [Related]
12. Molecular assessment of artemisinin resistance markers, polymorphisms in the k13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar.
Nyunt MH; Hlaing T; Oo HW; Tin-Oo LL; Phway HP; Wang B; Zaw NN; Han SS; Tun T; San KK; Kyaw MP; Han ET
Clin Infect Dis; 2015 Apr; 60(8):1208-15. PubMed ID: 25537878
[TBL] [Abstract][Full Text] [Related]
13. High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.
Warsame M; Hassan AM; Hassan AH; Jibril AM; Khim N; Arale AM; Gomey AH; Nur ZS; Osman SM; Mohamed MS; Abdulrahman A; Yusuf FE; Amran JGH; Witkowski B; Ringwald P
Malar J; 2019 Jul; 18(1):231. PubMed ID: 31296223
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy and artemisinin resistance in northern Myanmar: evidence from in vivo and molecular marker studies.
Myint MK; Rasmussen C; Thi A; Bustos D; Ringwald P; Lin K
Malar J; 2017 Apr; 16(1):143. PubMed ID: 28388902
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013.
Dorkenoo AM; Yehadji D; Agbo YM; Layibo Y; Agbeko F; Adjeloh P; Yakpa K; Sossou E; Awokou F; Ringwald P
Malar J; 2016 Jun; 15():331. PubMed ID: 27334876
[TBL] [Abstract][Full Text] [Related]
16.
Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
[TBL] [Abstract][Full Text] [Related]
17. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
18. Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.
Tun KM; Jeeyapant A; Imwong M; Thein M; Aung SS; Hlaing TM; Yuentrakul P; Promnarate C; Dhorda M; Woodrow CJ; Dondorp AM; Ashley EA; Smithuis FM; White NJ; Day NP
Malar J; 2016 Mar; 15():185. PubMed ID: 27036739
[TBL] [Abstract][Full Text] [Related]
19. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.
Uwimana A; Umulisa N; Venkatesan M; Svigel SS; Zhou Z; Munyaneza T; Habimana RM; Rucogoza A; Moriarty LF; Sandford R; Piercefield E; Goldman I; Ezema B; Talundzic E; Pacheco MA; Escalante AA; Ngamije D; Mangala JN; Kabera M; Munguti K; Murindahabi M; Brieger W; Musanabaganwa C; Mutesa L; Udhayakumar V; Mbituyumuremyi A; Halsey ES; Lucchi NW
Lancet Infect Dis; 2021 Aug; 21(8):1120-1128. PubMed ID: 33864801
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
Ebong C; Sserwanga A; Namuganga JF; Kapisi J; Mpimbaza A; Gonahasa S; Asua V; Gudoi S; Kigozi R; Tibenderana J; Bwanika JB; Bosco A; Rubahika D; Kyabayinze D; Opigo J; Rutazana D; Sebikaari G; Belay K; Niang M; Halsey ES; Moriarty LF; Lucchi NW; Souza SSS; Nsobya SL; Kamya MR; Yeka A
Malar J; 2021 Dec; 20(1):484. PubMed ID: 34952573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
